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. Introduction
known etiology, although genetic predisposition is likely to be important [2, 3] . The main pathologic feature of the Sarcoidosis, a disease predominantly affecting young disease is a chronic inflammation resulting in non-caseatadults, is the most common diffuse lung disease with a ing granuloma formation. The prognosis of sarcoidosis is population prevalence of around 1:4000 [1, 2] . Sarcoidosis rather variable. A great deal of uncertainty exists as to how is an immune-mediated inflammatory disease with unto predict the natural course of the (untreated) disease and how to identify those individual cases who should be treated immediately. More important, as it is still not q Data from this manuscript were partly presented at the 7th World possible to identify the cause of sarcoidosis, therapy is Association of Sarcoidosis and Other Granulomatous Disorders, [16] [17] [18] [19] directed at controlling the inflammatory reaction [4] . to reflect the severity of sarcoidosis [5] [6] [7] [8] [9] . Notably, the described functional promotor polymorphisms, namely, the 2463 G /A MPO promotor polymorphism [15, 16] and the recently described 2129 G /A promotor polymorphism [17] . Several diseases have been reported to be associated 2 .2. Evaluating sarcoidosis pulmonary disease severity with the 2463 G /A promotor polymorphism [16, [18] [19] [20] [21] [22] , whereas no association studies of 2129 G /A have yet been Chest radiographs were graded according to the radiogreported.
raphic staging of DeRemee (0 to III), adding stage IV, the MPO appears to be involved in tissue damage through end stage of lung fibrosis [2, 27] . With high-resolution production of the potent oxidant HOCl, which is able to computer tomography (HRCT), thin-section scans with oxidize many cellular compounds, such as thiols and 1-mm collimation were obtained at 10-mm intervals NADPH, and to lead to chlorination of DNA bases and through the chest. The scanning parameters included 137 tyrosine residues in proteins [11, 12, [23] [24] [25] . Therefore, it kVp, 255 mA, and 1-s scanning time. can be assumed that decreased availability of MPO, related Both mediastinal (width 400 HU; level 40 HU) and lung to functional MPO promotor polymorphisms, has a protec-(width 1600 HU; level 2800 HU) window images were tive effect by decreasing the chance of tissue damage.
obtained. The semiquantitive HRCT scoring system was It has been hypothesized that the MPO polymorphism used as described previously [28] . may contribute, at least in part, to disease severity in Lung function parameters, including the forced expiratsarcoidosis and make it possible to determine those cases ory volume in 1 s (FEV ) and forced vital capacity (FVC), 1 who might benefit from agents controlling the inflammawere measured with a pneumotachograph. The diffusing tory reaction at an early stage. Hence, the incidence of two capacity for carbon monoxide (DL ) was measured using CO MPO promotor polymorphisms (2463 G /A and 2129 the single-breath method (both Masterlab, Jaeger, G /A) was analyzed in a Dutch Caucasian sarcoidosis Wurzburg, Germany). Values were expressed as a perpopulation, as was their possible relationship with disease centage of those predicted [29] . severity.
Serum ACE (sACE) was measured using the colorimetric method (Fujirebio Inc., Tokyo, Japan, cat. nr. FU 116). ACE acts on a substrate p-hydroxybenzoyl-glycyl-L-hystidyl-L-leucine and separates p-hydroxybenzoyl-glycine, 2 . Materials and methods which is converted in two consequent reactions in quinoneimine dye. The 2463 G /A polymorphism was determined as obtained from all participating subjects. Patient characpreviously described [16, 18, 19] . The 129G /A polymorteristics are summarized in Table 1 . phism was determined as described by Hoy et al. [17] . The significantly between patients with sarcoidosis and healthy controls (Table 3) . Furthermore, for both polymorphisms, 2 .4. Statistics sex-specific analysis showed no differences in allele or genotype frequencies (data not shown). All analyses were performed using SPSS 10.0 for Baseline clinical data of the patients with sarcoidosis are Windows (SPSS, Chicago, IL, USA). Agreement with presented in Table 4 . We also tested whether any associaHardy-Weinberg equilibrium and differences in allele and tion could be found with MPO polymorphisms. For this genotype frequencies between groups were tested using purpose, for 2463 G /A polymorphism, the GA and AA chi-square tests. Because multiple comparisons were pergenotypes were grouped together and compared to the GG formed, a probability value divided by the number of genotype. No relationship with age at diagnosis was found. comparisons was considered statistically significant (BonSeverity of the disease was then evaluated in relation to ferroni's correction). Univariate logistic regression analysis genotype. The results of this analysis are presented in was used to calculate odds ratios with 95% confidence Table 5 . As can be seen, no significant differences in the intervals. Group comparisons were performed by means of severity, as presented by clinical data, could be found. This an Independent samples t-test or the Mann-Whitney Ufinding remained unchanged after correcting for prednisone test.
use. The same analysis that is shown in Table 5 repeated with respect to 2129 G /A polymorphism. No corticosteroid use, treated and untreated sarcoidosis parelationship to clinical data was found (data not shown).
tients were also considered separately. The results in both subgroups appeared to be similar to those in the total population, i.e. no relationship to MPO genotype (also 4 . Discussion after stratification for sex and age) was found.
Of the cells present in BALF, PMNs are considered to This study showed that the distribution of two functional be a key mediator indicative of severity of the disease. In MPO promotor polymorphisms, 2463G /A and 2129G /A, cases with more extensive long-term radiographic features, was similar in both sarcoidosis patients and controls. No impaired lung function parameters, a poor prognosis, and relationship was found between these polymorphisms and sometimes corticosteroid-resistant chronic disease, PMNs disease severity. To exclude a possible bias due to were found to be increased in BALF [5] [6] [7] 9 ]. Moreover, a strong correlation exists between MPO level and PMN of the disease who might benefit from early treatment of count in BALF [14] . the inflammatory reaction. Some could argue that the neutrophils might just be an epiphenomenon, appearing when disease is extensive and fibrotic. However, it was recently demonstrated that the A cknowledgements number of neutrophils in BALF, even at first presentation, is indicative of prognosis and disease outcome [5, 9] .
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